Veracyte
VCYT
43.16
-1.49
-3.34%
Veracyte
US · VCYT
#2330 by market cap
Listed 1970
43.16
-1.49
-3.34%
Live - 5344 symbols - heartbeat 6s ago
· 2026-10-08 06:26
Pre-market
42.82
-0.79%
After-hours
43.16
0.00%
Overnight
43.00
-0.37%
- Market cap
- 3.47B
- P/E (TTM)i
- 30.83
- P/Bi
- 2.50
- EPSi
- 0.82
- Div yieldi
- 0.00%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on VCYT?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
William Blair Maintains Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/5/28
-
Rating change
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $66Market Newswire · 2026/7/31
-
UBS Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/9/9
-
Rating change
Jefferies Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $70Market Newswire · 2026/7/9
-
Rating change
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/6/29
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $57Market Newswire · 2026/6/1
-
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54Market Newswire · 2026/9/17
-
Rating change
Piper Sandler Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $66Market Newswire · 2026/7/15
-
Rating change
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Raises Target Price to $60Market Newswire · 2026/7/14
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $69Market Newswire · 2026/7/31
-
Rating change
William Blair Initiates Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/7/31
-
Rating change
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $50Market Newswire · 2026/8/3
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $69Market Newswire · 2026/9/15
-
Craig-Hallum Maintains Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/9/16
-
Freedom Capital Markets Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $66Market Newswire · 2026/9/15
-
Rating change
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Cuts Target Price to $44Market Newswire · 2026/8/4
-
Rating change
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $54Market Newswire · 2026/8/4
-
Rating change
Stephens Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $55Market Newswire · 2026/8/4
-
Rating change
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $47Market Newswire · 2026/7/9
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 06:26:05 · For reference only, not investment advice and not tailored to your situation.